Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis

Nathalie Pamir, Francis C. Lynn, Alison M J Buchan, Jan Ehses, Simon A. Hinke, J. Andrew Pospisilik, Kazumasa Miyawaki, Yuichiro Yamada, Yutaka Seino, Christopher H S McIntosh, Raymond A. Pederson

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are gut hormones that act via the enteroinsular axis to potentiate insulin secretion from the pancreas in a glucose-dependent manner. Both GLP-1 receptor and GIP receptor knockout mice (GLP-1R-/- and GIPR-/-, respectively) have been generated to investigate the physiological importance of this axis. Although reduced GIP action is a component of type 2 diabetes, GIPR-deficient mice exhibit only moderately impaired glucose tolerance. The present study was directed at investigating possible compensatory mechanisms that take place within the enteroinsular axis in the absence of GIP action. Although serum total GLP-1 levels in GIPR knockout mice were unaltered, insulin responses to GLP-1 from pancreas perfusions and static islet incubations were significantly greater (40-60%) in GIPR-/- than in wild-type (GIPR+/+) mice. Furthermore, GLP-1-induced cAMP production was also elevated twofold in the islets of the knockout animals. Pancreatic insulin content and gene expression were reduced in GIPR-/- mice compared with GIPR+/+ mice. Paradoxically, immunocytochemical studies showed a significant increase in β-cell area in the GIPR-null mice but with less intense staining for insulin. In conclusion, GIPR-/- mice exhibit altered islet structure and topography and increased islet sensitivity to GLP-1 despite a decrease in pancreatic insulin content and gene expression.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume284
Issue number5 47-5
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Glucagon-Like Peptide 1
Insulin
Glucose
Gene expression
Knockout Mice
Peptides
Pancreas
Incretins
Polypeptides
Gene Expression
Medical problems
Glucose Intolerance
Topography
Animals
Type 2 Diabetes Mellitus
gastric inhibitory polypeptide receptor
Hormones
Perfusion
Staining and Labeling
Serum

Keywords

  • CAMP
  • GLP-1
  • Incretin
  • Insulin
  • Pancreas perfusion

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Biochemistry

Cite this

Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. / Pamir, Nathalie; Lynn, Francis C.; Buchan, Alison M J; Ehses, Jan; Hinke, Simon A.; Pospisilik, J. Andrew; Miyawaki, Kazumasa; Yamada, Yuichiro; Seino, Yutaka; McIntosh, Christopher H S; Pederson, Raymond A.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 284, No. 5 47-5, 01.05.2003.

Research output: Contribution to journalArticle

Pamir, N, Lynn, FC, Buchan, AMJ, Ehses, J, Hinke, SA, Pospisilik, JA, Miyawaki, K, Yamada, Y, Seino, Y, McIntosh, CHS & Pederson, RA 2003, 'Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis', American Journal of Physiology - Endocrinology and Metabolism, vol. 284, no. 5 47-5.
Pamir, Nathalie ; Lynn, Francis C. ; Buchan, Alison M J ; Ehses, Jan ; Hinke, Simon A. ; Pospisilik, J. Andrew ; Miyawaki, Kazumasa ; Yamada, Yuichiro ; Seino, Yutaka ; McIntosh, Christopher H S ; Pederson, Raymond A. / Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. In: American Journal of Physiology - Endocrinology and Metabolism. 2003 ; Vol. 284, No. 5 47-5.
@article{cf8305efb8ee4a79b91bf0deb431b863,
title = "Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis",
abstract = "The incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are gut hormones that act via the enteroinsular axis to potentiate insulin secretion from the pancreas in a glucose-dependent manner. Both GLP-1 receptor and GIP receptor knockout mice (GLP-1R-/- and GIPR-/-, respectively) have been generated to investigate the physiological importance of this axis. Although reduced GIP action is a component of type 2 diabetes, GIPR-deficient mice exhibit only moderately impaired glucose tolerance. The present study was directed at investigating possible compensatory mechanisms that take place within the enteroinsular axis in the absence of GIP action. Although serum total GLP-1 levels in GIPR knockout mice were unaltered, insulin responses to GLP-1 from pancreas perfusions and static islet incubations were significantly greater (40-60{\%}) in GIPR-/- than in wild-type (GIPR+/+) mice. Furthermore, GLP-1-induced cAMP production was also elevated twofold in the islets of the knockout animals. Pancreatic insulin content and gene expression were reduced in GIPR-/- mice compared with GIPR+/+ mice. Paradoxically, immunocytochemical studies showed a significant increase in β-cell area in the GIPR-null mice but with less intense staining for insulin. In conclusion, GIPR-/- mice exhibit altered islet structure and topography and increased islet sensitivity to GLP-1 despite a decrease in pancreatic insulin content and gene expression.",
keywords = "CAMP, GLP-1, Incretin, Insulin, Pancreas perfusion",
author = "Nathalie Pamir and Lynn, {Francis C.} and Buchan, {Alison M J} and Jan Ehses and Hinke, {Simon A.} and Pospisilik, {J. Andrew} and Kazumasa Miyawaki and Yuichiro Yamada and Yutaka Seino and McIntosh, {Christopher H S} and Pederson, {Raymond A.}",
year = "2003",
month = "5",
day = "1",
language = "English (US)",
volume = "284",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5 47-5",

}

TY - JOUR

T1 - Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis

AU - Pamir, Nathalie

AU - Lynn, Francis C.

AU - Buchan, Alison M J

AU - Ehses, Jan

AU - Hinke, Simon A.

AU - Pospisilik, J. Andrew

AU - Miyawaki, Kazumasa

AU - Yamada, Yuichiro

AU - Seino, Yutaka

AU - McIntosh, Christopher H S

AU - Pederson, Raymond A.

PY - 2003/5/1

Y1 - 2003/5/1

N2 - The incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are gut hormones that act via the enteroinsular axis to potentiate insulin secretion from the pancreas in a glucose-dependent manner. Both GLP-1 receptor and GIP receptor knockout mice (GLP-1R-/- and GIPR-/-, respectively) have been generated to investigate the physiological importance of this axis. Although reduced GIP action is a component of type 2 diabetes, GIPR-deficient mice exhibit only moderately impaired glucose tolerance. The present study was directed at investigating possible compensatory mechanisms that take place within the enteroinsular axis in the absence of GIP action. Although serum total GLP-1 levels in GIPR knockout mice were unaltered, insulin responses to GLP-1 from pancreas perfusions and static islet incubations were significantly greater (40-60%) in GIPR-/- than in wild-type (GIPR+/+) mice. Furthermore, GLP-1-induced cAMP production was also elevated twofold in the islets of the knockout animals. Pancreatic insulin content and gene expression were reduced in GIPR-/- mice compared with GIPR+/+ mice. Paradoxically, immunocytochemical studies showed a significant increase in β-cell area in the GIPR-null mice but with less intense staining for insulin. In conclusion, GIPR-/- mice exhibit altered islet structure and topography and increased islet sensitivity to GLP-1 despite a decrease in pancreatic insulin content and gene expression.

AB - The incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are gut hormones that act via the enteroinsular axis to potentiate insulin secretion from the pancreas in a glucose-dependent manner. Both GLP-1 receptor and GIP receptor knockout mice (GLP-1R-/- and GIPR-/-, respectively) have been generated to investigate the physiological importance of this axis. Although reduced GIP action is a component of type 2 diabetes, GIPR-deficient mice exhibit only moderately impaired glucose tolerance. The present study was directed at investigating possible compensatory mechanisms that take place within the enteroinsular axis in the absence of GIP action. Although serum total GLP-1 levels in GIPR knockout mice were unaltered, insulin responses to GLP-1 from pancreas perfusions and static islet incubations were significantly greater (40-60%) in GIPR-/- than in wild-type (GIPR+/+) mice. Furthermore, GLP-1-induced cAMP production was also elevated twofold in the islets of the knockout animals. Pancreatic insulin content and gene expression were reduced in GIPR-/- mice compared with GIPR+/+ mice. Paradoxically, immunocytochemical studies showed a significant increase in β-cell area in the GIPR-null mice but with less intense staining for insulin. In conclusion, GIPR-/- mice exhibit altered islet structure and topography and increased islet sensitivity to GLP-1 despite a decrease in pancreatic insulin content and gene expression.

KW - CAMP

KW - GLP-1

KW - Incretin

KW - Insulin

KW - Pancreas perfusion

UR - http://www.scopus.com/inward/record.url?scp=18244424871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244424871&partnerID=8YFLogxK

M3 - Article

C2 - 12540373

AN - SCOPUS:18244424871

VL - 284

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5 47-5

ER -